x

RSS Newsfeeds

See all RSS Newsfeeds

Jul 28, 2017 2:25 PM ET

Global Biologics Market – Analysis and Forecast (2017-2025)

iCrowdNewswire - Jul 28, 2017

The “Global Biologics Market – Analysis and Forecast (2017-2025) (Focus on Pipeline Analysis, Product Type, Therapeutic Application, Country Analysis, and Market Dynamics)” report has been added to Research and Markets’ offering.

The biologics products are likely to account for 26% by value, of the global pharmaceutical products, by 2020. The report constitutes of an in-depth study of the biologics drug discovery market, including a thorough analysis of the products across different regions. The study also presents a detailed analysis of the market trends and the market size for the period, 2014 to 2025, wherein 2016 is the base year and the years from 2017 to 2025 is the forecast period. The report covers all the prevalent trends playing a major role in the growth of the market over the forecast period.

Biologics involve complex manufacturing procedures and are required to be maintained at pre-determined conditions as they are highly sensitive to changes in ambience. Consequently, companies need to invest huge amounts in terms of capital, to meet the standards, which will eventually increase the cost of biologics.

The introduction of biologic therapies gave a new ray of hope for people suffering from chronic inflammatory diseases. Biologics effected their life not only by reducing dependency on health and welfare systems but also by improving their physical function to live independently. The entry of biosimilars makes these effective therapies more affordable, though the concern of after effects still exists. Some industry experts also express their caution regarding the entry of biosimilars, which might add to the concerns of safety and after effects of the therapies.

Companies Mentioned

– AbbVie Inc.
– Allergan Plc
– Amgen Inc.
– Astellas Pharma Inc.
– AstraZeneca PLC
– Bayer AG
– Biocon Ltd.
– Boehringer Ingelheim GmbH
– Bristol-Myers Squibb Company
– Eli Lilly and Company
– F. Hoffmann-La Roche AG
– Gilead Sciences, Inc.
– GlaxoSmithKline Plc
– Johnson & Johnson
– Merck & CO., Inc.
– Merck KGaA
– Novartis AG
– Novo Nordisk
– Pfizer Inc.
– Sanofi
– Teva Pharmaceuticals Industries Limited

Key Topics Covered:

1 Report Scope and Methodology

2. Market Overview

3. Global Biologics Market by Therapeutics

4. Global Biologics Market by Product

5. Global Biologics Market by Geography

6. Competitive Landscape

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/mlp35s/global_biologics

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Biopharmaceuticals (https://www.researchandmarkets.com/categories.asp?cat_id=583&campaign_id=mlp35s)

Via iCrowdNewswire
View Related News >